Discussion about this post

User's avatar
Bruce Blumenthal's avatar

Kinda like looking at neutralizing antibodies, however transient, rather than severe illness, hospitalizations and death in covid vaccine studies

Expand full comment
J Lee MD PhD's avatar

Excellent article on "endpoint shenanigans". Thanks. I would like to see your thoughts on another matter that seems related and bothers me a lot: What is with this new-fangled gimmick of measuring so-called Composite Outcomes in clinical trials? Hypothetical Example: In a randomized, blinded trial, new drug X is put up against old drug Y and the Composite Outcome called (Death or Perianal Itching or Vision Problems) is measured for every person in each arm during a two-month followup interval. Shazam !! Patients who received X "had better composite outcomes" than patients who took Y. How in the hell can a doctor decide rationally from this kind of report whether a patient sitting in her office right now has a reasonable probability of gaining benefit if drug X is prescribed instead of drug Y ? Something about these kinds of "studies" smells fishy to me. The first thing I not infrequently notice is that any one of the three clinical outcome components in this kind of caper will have NOT shown a significant difference in compared groups. But .. .. .. .. .. I did not get an Ivy League undergrad degree so perhaps I have missed some nuances and subtle point(s). Please help. Thanks.

Expand full comment
54 more comments...

No posts